Antiinflammatory effect of topically applied propolis extract in carrageenan-induced rat hind paw edema

Phytotherapy Research

Volumn 21, Issue 5, 2007, Pages 452-456

  Naito, Yukiko ^a   Yasumuro, Misao ^b   Kondou, Keiichiro ^b   Ohara, Naoki ^a  

^a HATANO RESEARCH INSTITUTE   (Japan)

^b Nippon Zettoc Research Laboratory   (Japan)

Author keywords

Antiinflammation; Hind paw edema; Propolis; Rats; Topical application

Indexed keywords

AGAROSE; CARRAGEENAN; PROPOLIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; NEUTROPHIL; NONHUMAN; PAW EDEMA; RAT;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; CELLS, CULTURED; CHEMOTAXIS; EDEMA; HUMANS; MALE; NEUTROPHILS; PROPOLIS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 34248229864     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2093     Document Type: Article

References (30)

1. Bankova VS, de Castro SL, Marcucci MC. 2000. Propolis: recent advances in the chemistry and plant origin. Apidologie 31: 3-15.
2. Banskota AH, Tezuka Y, Kadota S. 2001. Recent progress in pharmacological research of propolis. Phytother Res 15: 561-571.
3. Burdock GA. 1998. Review of the biological properties and toxicity of bee propolis (propolis). Food Chem Toxicol 36: 347-363.
4. Cicala C, Morello S, Iorio C, Capasso R, Borrelli F, Mascolo N. 2003. Vascular effects of caffeic acid phenethyl ester (CAPE) on isolated rat thoracic aorta. Life Sci 73: 73-80.
5. de Castro SL. 2001. Propolis: Biological and pharmacological activities. Therapeutic uses of this bee-product. Ann Rev Biomed Sci 3: 49-83.
6. Dobrowolski JW, Vohora SB, Sharma K, Shah SA, Naqvi SAH, Dandiya PC. 1991. Antibacterial, antifungal, antiamoebic, antiinflammatory and antipyretic studies on propolis bee products. J Ethnopharmacol 35: 77-82.
7. Gregory SR, Piccolo N, Piccolo MT, Piccolo MS, Heggers JP. 2002. Comparison of propolis skin cream to silver sulfadiazine: a naturopathic alternative to antibiotics in treatment of minor burns. J Altern Complement Med 8: 77-83.
8. Han S, Sung KH, Yim D et al. 2002. Activation of murine macrophage cell line Raw 264.7 by Korean propolis. Arch Pharm Res 25: 895-902.
9. Hausen BM, Wollenweber E, Senff H, Post B. 1987a. Propolis allergy. (I). Origin, properties, usage and literature review. Contact Dermat 17: 163-170.
10. Hausen BM, Wollenweber E, Senff H, Post B. 1987b. Propolis allergy. (II). The sensitizing properties of 1, 1-dimethylallyl caffeic acid ester. Contact Dermat 17: 171-177.
11. Hepsen IF, Er H, Cekic O. 1999. Topically applied water extract of propolis to suppress corneal neovascularization in rabbits. Ophthal Res 31: 426-431.
12. Hosnuter M, Gurel A, Babuccu O, Armutcu F, Kargi E, Isikdemir A. 2004. The effect of CAPE on lipid peroxidation and nitric oxide levels in the plasma of rats following thermal injury. Burns 30: 121-125.
13. Ichikawa H, Satoh K, Tobe T et al. 2002. Free radical scavenging activity of propolis. Redox Rep 7: 347-350.
14. Khayyal MT, el-Ghazaly MA, el-Khatib AS. 1993. Mechanisms involved in the antiinflammatory effect of propolis extract. Drugs Exp Clin Res 19: 197-203.
15. Krol W, Scheller S, Czuba Z et al. 1996. Inhibition of neutrophils' chemiluminescence by ethanol extract of propolis (EEP) and its phenolic components. J Ethnopharmacol 55: 19-25.
16. Maffia P, Ianaro A, Pisano B et al. 2002. Beneficial effects of caffeic acid phenethyl ester in a rat model of vascular injury. Br J Pharmacol 136: 353-360.
17. Magro-Filho O, de Carvalho AC. 1994. Topical effect of propolis in the repair of sulcoplasties by the modified Kazanjian technique. Cytological and clinical evaluation. J Nihon Univ Sch Dent 36: 102-111.
18. Marcucci MC. 1995. Propolis: chemical composition, biological properties and therapeutic activity. Apidologie 26: 83-99.
19. Michaluart P, Masferrer JL, Carothers AM et al. 1999. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res 59: 2347-2352.
20. Mizoeva OK, Calder PC. 1996. The effect of propolis and its components on eicosanoid production during the inflammatory response. Prostaglandins Leukot Essent Fatty Acids 55: 441-449.
21. Murray MC, Worthington HV, Blinkhorn AS. 1997. A study to investigate the effect of a propolis-containing mouthrinse on the inhibition of de novo plaque formation. J Clin Periodontal 24: 796-798.
22. Nagaoka T, Banskota AH, Tezuka Y, Midorikawa K, Matsushige K, Kadota S. 2003. Caffeic acid phenethyl ester (CAPE) analogues: potent nitric oxide inhibitors from the Netherlands propolis. Biol Pharm Bull 26: 487-491.
23. Orban Z, Mitsiades N, Burke TR Jr, Tsokos M, Chrousos GP. 2000. Caffeic acid phenethyl ester induces leukocyte apoptosis, modulates nuclear factor-kappa B and suppresses acute inflammation. Neuroimmunomodulation 7: 99-105.
24. Park E-H, Kahng J-H. 1999. Suppressive effects of propolis in rat adjuvant arthritis. Arch Pharm Res 22: 554-558.
25. Paulino N, Dantas AP, Bankova V et al. 2003. Bulgarian propolis induces analgesic and anti-inflammatory effects in mice and inhibits in vitro concentration of airway smooth muscle. J Pharmacol Sci 93: 307-313.
26. Song YS, Park E-H, Hur GM, Ryu YS, Kin YM, Jin C. 2002a. Ethanol extract of propolis inhibits nitric oxide synthase gene expression and enzyme activity. J Ethnopharmacol 88: 155-161.
27. Song YS, Park EH, Jung KJ, Jin C. 2002b. Inhibition of angiogenesis by propolis. Arch Pharm Res 25: 500-504.
28. Tatefuji T, Izumi N, Ohta T, Arai S, Ikeda M, Kurimoto M. 1996. Isolation and identification of compounds from Brazilian propolis which enhance macrophage spreading and mobility. Biol Pharm Bull 19: 966-970.
29. Vinegar R, Schreiber W, Hugo R. 1969. Biphasic development of carrageenin edema in rats. J Pharmacol Exp Ther 166: 96-103.
30. Walker P, Crane E. 1987. Constituents of propolis. Apidologie 18: 327-334.